DOXIX | NEFRX | DOXIX / NEFRX | |
Total Expense Ratio | 0.33 | 0.74 | 45% |
Annual Report Gross Expense Ratio | 0.36 | 0.75 | 48% |
Fund Existence | 3 years | 52 years | - |
Gain YTD | 3.643 | 3.801 | 96% |
Front Load | N/A | 4% | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 96.6B | 7.68B | 1,258% |
Annual Yield % from dividends | 4.33 | 3.95 | 110% |
Returns for 1 year | 4.99 | 4.23 | 118% |
Returns for 3 years | 12.77 | 8.38 | 152% |
Returns for 5 years | N/A | -5.21 | - |
Returns for 10 years | N/A | 19.89 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IFRA | 50.02 | 0.06 | +0.12% |
iShares US Infrastructure ETF | |||
BBIB | 98.17 | N/A | N/A |
JPMorgan BetaBuilders U.S.TrsBd3-10YrETF | |||
HEGD | 23.53 | -0.05 | -0.21% |
Swan Hedged Equity US Large Cap ETF | |||
PAI | 13.02 | -0.04 | -0.31% |
Western Asset Investment Grade Income Fund | |||
GLOW | 28.32 | -0.24 | -0.82% |
VictoryShares WestEnd Global Equity ETF |